New study identifies genes and cell types that potentially contribute to primary open-angle glaucoma formation

News
Article

Findings from Mass Eye and Ear’s collaborative study provides new insights regarding gene expression and post-transcriptional gene regulation.

Woman in lab looking into test tub Image Credit: AdobeStock/ViacheslavYakobchuk

Image Credit: AdobeStock/ViacheslavYakobchuk

A new study has uncovered genes, biological processes, and cell types that may affect the pathogenesis of primary open-angle glaucoma (POAG). The study, published in Nature Communications by Mass Eye and Ear researchers, came to these conclusions by combining “genetic discoveries from a large cross-ancestry genome-wide association study meta-analysis of POAG and a large meta-analysis of intraocular pressure (IOP) with genetic regulation studies and single cell expression measurements in glaucoma-relevant eye tissues,” according to a news brief.

Work for the study was completed in collaboration with the International Glaucoma Genetics Consortium, along with the laboratories of Josh Sanes, Harvard University; Rui Chen, Baylor College of Medicine; Veronique Vitart, The University of Edinburgh; Skanda Rajasundaram, Imperial College London; and Anand Swaroop, NEI. The study on the meta-analysis of POAG was led by Janey Wiggs, MD, PhD.1

“Our work has generated new insights into POAG mechanisms, which could inform the development of novel therapies targeting IOP reduction and neuroprotection,” said Ayellet Segré, PhD, in the release. “For example, this research suggests that targeting neuronal support cells, in addition to retinal ganglion cells, may be important to consider in the design of new drug and cell therapies. Through our ongoing work aimed at detecting genetic regulation of gene expression in glaucoma-relevant eye tissues, we hope in the future to provide a more complete understanding of POAG risk and IOP variation.”

Hundreds of genes and regulatory effects were found to underlay over 100 loci associated with either, or both, POAG and IOP, by the group of researchers, led by Segré. These loci contribute to glaucoma risk by means of altering gene expression levels.1 “These genes are enriched in biological pathways implicated in disease mechanisms, including elastic fiber formation and extracellular matrix organization, vascular development, and neuronal related processes,” stated the brief.

Researchers were also able to identify less well-established cell types where gene dysregulation could affect optic nerve degeneration. The researchers compiled data from fibroblasts in conventional and unconventional outflow pathways, as well as the surrounding region of the optic nerve head, astrocytes in the retina and optic nerve head and oligodendrocytes and vascular cells in the optic nerve head to come to these conclusions. As a whole, the single-nucleus gene expression data was sourced from aqueous humor outflow pathways, retina, and the optic nerve head and surrounding posterior tissues.1

The brief stated that identifying these pathways can provide new insights regarding gene expression and post-transcriptional gene regulation. This could lead to drug design improvements for glaucoma.

Reference:
  1. Researchers identify genes and cell types that may have causal role in primary open-angle glaucoma. Mass Eye and Ear. Research Brief. Published February 15, 2024. Accessed February 19, 2024. https://www.masseyeandear.org/news/articles/2024/researchers-identify-genes-cell-types-primary-open-angle-glaucoma-formation
Recent Videos
Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.
Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.
Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
From new treatments on the horizon for macular degeneration to strengthening comanagement ties, optometrists cite a lot to be excited about in the coming year.
Practice owners testify to the importance of trying new things, not being afraid to fail, and utilizing community as a resource when starting up a new practice.
Optometrists reflect on their residency experiences and provide advice to current residents.
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
© 2025 MJH Life Sciences

All rights reserved.